JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B6032 CB-5083

Target: p97

Summary: p97 inhibitor

insoluble in H2O; ≥20.65 mg/mL
B2151 STF-62247

Target: Autophagy

Summary: Autophagy inducer in renal cell
A4443 Gliotoxin
1 Citation

Target: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|Farnesyltransferase

Summary: 20S proteasome inhibitor

Soluble in DMSO
A4429 Vialinin A

Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2

Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor

Soluble in DMSO
A3966 Doxorubicin
3 Citation

Summary: Topo II inhibitor,immunosuppresive antineoplastic antibiotic

≥27.2 mg/mL
A8212 PR-619

Target: Deubiquitinating enzymes (DUBs)

Summary: Deubiquitylating enzymes (DBUs) inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
A8250 LY 294002
16 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A2845 Omeprazole

Summary: H+,K+-ATPase inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.27 mg/mL
A2324 Dexamethasone (DHAP)

Target: interleukin receptor

Summary: Glucocorticoidan; anti-inflammatory

insoluble in H2O; ≥19.623 mg/mL
A8323 WP1130
1 Citation

Summary: Deubiquitinase (DUB) inhibitor, Cell permeable

≥38.4 mg/mL